Prof. Arindam Mukherjee
Department of Chemical Sciences Indian Institute of Science Education and Research Kolkata Mohanpur, West Bengal, India Email: [email protected] |
|
The GroupAM group is inspired by methodology of designing metal based anticancer agents and small organic molecules that would be resistant to efflux outside cells, inhibit proteins relevant to signalling growth of blood vessels, inhibit cholesterol absorption, active against cancer stem cells or boost the immune system to recognize cancer. Ph.D. students in the AM lab engage in a comprehensive research workflow, encompassing synthesis, characterization, and in vitro studies using both cancer and primary cell lines to assess cytotoxicity. Throughout their training, students gain expertise in organic and inorganic synthesis, analytical characterization, biochemical assays, and essential molecular biology techniques, equipping them with a multidisciplinary skill set for cutting-edge cancer research. We have established a network of collaboration for studying the impact of our compounds on biological systems with Dr. Arnab Gupta (Department of Biological Sciences, IISER Kolkata), Dr. Rahul Das (Department of Biological Sciences, IISER Kolkata), Dr. Sandeep Singh (National Institute of Biomedical Genomics, Kalyani) and Dr. Moulinath Acharya (National Institute of Biomedical Genomics, Kalyani).Dr. B Kiran Kumar (The Centre for Cellular & Molecular Biology (CCMB), Hyderabad).
|
Our HistoryDr. Arindam Mukherjee is an inorganic chemist by training and joined IISER Kolkata on July 2009. The synthetic lab started functioning in 2011 with the help of infrastructure and facilities given by IISER Kolkata. The cell culture facility was established with the help of funding from DST and IISER Kolkata in June 2012. The research group exclusively admits Ph.D. students with a chemistry background, including those with BS-MS, MS, or M.Sc. degrees, regardless of specialization. However, a strong commitment to organic synthesis is essential. The lab focuses extensively on multi-step (3–7 steps) organic synthesis for developing prodrug-type ligands incorporating clinically approved or trial-stage drugs. Prospective students interested in joining the group should align their project proposals with this research direction.
We welcome Post-doctoral fellows with independent fellowships from various funding agencies, viz. SERB N-PDF.
|
